Autosomal dominant porencephaly type I

Lore & Background

Autosomal dominant porencephaly type I is a rare condition whose prevalence and incidence remain unknown. It affects males and females equally. The disorder is caused by mutations in the COL4A1 gene, located at band 34 on the long arm of chromosome 13. This gene codes for collagen type IV, a key component of the vascular basement membrane; when defective, the basement membrane weakens, making blood vessels susceptible to damage or rupture, particularly in the skull or brain, leading to cyst formation.

Reader's Guide

The significance of autosomal dominant porencephaly type I lies in its demonstration of how a single gene mutation affecting vascular integrity can produce a wide spectrum of neurological symptoms. Because the COL4A1 mutation is inherited in an autosomal dominant pattern, family history is often relevant. Diagnosis is definitively made by genetic testing, though CT or MRI can suggest the condition. The disorder must be distinguished from other conditions such as brain small vessel disease with hemorrhage, HANAC syndrome, CADASIL syndrome (caused by a different gene), and sporadic porencephaly. Treatment is symptom-based, with anticonvulsants for seizures and blood pressure control for those with hypertension to reduce stroke risk. Avoiding anticoagulants, smoking, and head trauma is also recommended. The variability in symptom onset—from infancy to adulthood—and the range of manifestations, including migraines, strokes, dystonia, speech disorders, and hydrocephalus, underscore the complexity of managing this rare disease.

Did You Know?

• Autosomal dominant porencephaly type I is caused by mutations in the COL4A1 gene at 13q34.
• Symptoms may manifest as early as infancy or as late as adulthood.
• The disorder affects males and females equally.
• Treatment includes avoiding anticoagulants, smoking, and situations that may lead to head trauma.